RV299
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RV299, covering 2024-10-21 to 2024-10-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV) [Phase 1]